ERIN RUDIAK: Open Payments
NPI 1013540319 · FAIRFAX, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,090 in 56 payments from 15 companies in 2025. Trend: 2023 $428 · 2024 $1,174 · 2025 $1,090
Food & beverage: $1,090
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 12 | $243 |
| ABBVIE INC. | 14 | $229 |
| PFIZER INC. | 7 | $139 |
| AstraZeneca Pharmaceuticals LP | 5 | $103 |
| Lilly USA, LLC | 4 | $80 |
| Otsuka America Pharmaceutical, Inc. | 4 | $68 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $51 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $25 |
| Corcept Therapeutics | 1 | $25 |
| Daiichi Sankyo Inc. | 1 | $23 |
Products named: Ozempic, NURTEC ODT, Wegovy, QULIPTA, KISUNLA, UBRELVY, VRAYLAR, REXULTI.
Industry payments across VA — which companies pay providers there.
